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Objectives: To describe the clinical characteristics of septic pulmonary embolism in adults in
order to improve its diagnosis and treatment.
Methods: Specific search terms were used for retrieval from commonly used Chinese and En-
glish databases and the articles were selected in accordance with the inclusion and exclusion
criteria. Cases from the included articles were pooled; then the following parameters were
analyzed: major risk factors, clinical manifestations, imaging findings, characteristics of path-
ogenic microorganisms, complications and other clinical characteristics.
Results: After strictly selected by the inclusion and exclusion criteria, 76 articles were
selected (2 Chinese articles and 74 English articles) that described 168 cases. The major risk
factors for SPE were intravenous drug use (n Z 44), intravascular indwelling catheter
(n Z 21) and skin or soft tissue purulent infection (n Z 10). The most frequent clinical man-
ifestations were fever (n Z 144), dyspnea (n Z 81), chest pain (n Z 82) and cough (n Z 69).
Chest CT showed multiple peripheral nodules in both lungs (nZ 89), cavitation (nZ 75), focal
or wedge-shaped infiltrates (n Z 48) and pleural effusion (n Z 40). Echocardiography often
revealed vegetations (n Z 52). Blood cultures grew methicillin-resistant Staphylococcus
aureus (MRSA) (n Z 27), methicillin-sensitive Staphylococcus aureus (MSSA) (n Z 48) and
Candida (n Z 6). Seventeen cases died and 101 cases were cured.
Conclusions: SPE is a rare disease without specific clinical manifestations. For high-risk groups,
such as intravenous drug users or patients with intravascular indwelling catheters, fever and
imaging findings of multiple nodules or local infiltrates, with or without cavitation, are highly
suggestive of SPE. Early diagnosis and prompt antimicrobial therapy or surgical intervention
can lead to a successful treatment outcome.
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nary embolism in which emboli containing pathogens
embolize to the pulmonary artery and cause pulmonary
embolism and focal lung abscesses. In 1978, a study [1]
reported 60 cases of SPE, 78% of these were intravenous
drug users [1]. Due to the increasing use of intravascular
devices and catheters, more catheter-related SPE reports
have been published [2]; most were small case series or
individual case reports. In order to understand more thor-
oughly the clinical and epidemiological features of SPE, we
systematic reviewed reports of SPE published from June
1978 to September 2012. The results are reported below.Materials and methods
Sources of data
Septic pulmonary embolism was the search term used for
retrieval from the Chinese Biomedical Literature Database
on Disc, China National Knowledge Infrastructure, Wan-
fang Data Periodicals System and VIP Chinese Biomedical
Journals. In addition, “septic pulmonary embolism” and
“septic pulmonary emboli” were the search terms for
retrieval from PubMed, EBSCO, SpringerLink, ScienceDirect
Editons and EMBASE full-text database. Articles published
in the time period June 1,1978 to September 1, 2012 were
included. The retrieval was supplemented by literature
tracing to collect relevant articles as comprehensively as
possible. First, two investigators independently read the
titles and abstracts of the articles retrieved; second, after
excluding obviously ineligible reports, we browsed the full
texts of articles that might meet the inclusion criteria;
third, we cross-checked the results of the included articles.
In case of disagreement, eligibility was decided through
discussion or by a third investigator.Inclusion and exclusion criteria
Inclusion criteria were as follows: (1) Eligible study designs
included individual case reports, case series, caseecontrol
studies or cohort studies. (2) Case definition of SPE
included the following [2]: a. focal or multifocal lung in-
filtrates compatible with septic embolism to the lung, b.
presence of active extra pulmonary infection as potential
embolic source, c. exclusion of other potential explanation
for lung infiltrates and d. resolution of lung infiltrates with
appropriate antimicrobial therapy. (3) Study objectives
included a descriptive analysis of clinical manifestations of
SPE. (4) Study results could be either a qualitative
description of clinical manifestations or a quantitative
representation of the frequency of various clinical mani-
festations. (5) The patients in the studies were older than
14 years of age.
Exclusion criteria follow: (1) articles that only focused
on certain clinical characteristics of SPE, for example,
imaging characteristics; (2) articles that repeated
another published report or contained data that signifi-
cantly overlapped with that of another published report;
(3) systematic review, guidelines and other descriptive
articles and (4) articles without an available full text
version or published in languages other than Chinese and
English.Information extraction
EpiData 3.1 software was used to extract the relevant in-
formation from the eligible articles, including first author,
publication year, number of cases, age, sex, risk factors
and number of patients with these risk factors, clinical
manifestations, imaging findings, blood culture results and
outcomes, etc.
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SPSS13.0 software was used for statistical analysis of the
data. The included cases served as independent large
sample data for statistical analysis of various risk factors,
clinical symptoms, imaging characteristics, blood culture
results and outcomes.
Results
Description of the selected articles
In this study, we retrieved 338 relevant articles, 31 in
Chinese and 307 in English. After rigorous application of the
inclusion and exclusion criteria 76 eligible articles were
included, 2 in Chinese [3,4] and 74 in English [2,5e77]. All
included articles were individual case reports or serial case
reports; the distribution of the articles by publication year
is shown in Fig. 1.
Sociodemographic description of the cases
The 76 articles included a total of 168 cases of SPE, 113
males (67.26%) and 55 females (32.74%). All the cases were
14e81years old (mean 37.20  16.63 years). National and
regional distribution follow: 65 cases (38.69%) were from
the USA, 25 cases (14.88%) from the PRC, 23 cases (13.69%)
from South Korea, 13 cases (7.74%) from Taiwan, 13 cases
(7.74%) from Japan, 6 cases (3.57%) from Turkey, 4 cases
(2.38%) from the UK, 4 cases (2.38%) from Australia, 2 cases
from Germany, 2 cases from Portugal and 1 case each from
the Netherlands, Italy, Spain, Poland, Romania, Canada,
Egypt, Denmark, Malaysia, Brazil and India.
Primary infective foci
Among all cases, the primary infective focus was unknown
in 10 cases; 44 cases (26.19%) were drug addicts; 21 cases
(12.5%) had intravascular indwelling catheters; 20 cases
(11.91%) had infective endocarditis, 15 cases (8.93%) had
liver abscesses, 10 cases (5.95%) had skin and soft tissue
infections, 10 cases (5.95%) had septic thrombophlebitis, 9
cases (5.36%) had lemierre’s syndrome, 9 cases (5.36%) had
dental and periodontal infections; 5 cases (2.98%) had heart
pacemakers, 4 cases had throat abscesses, 4 cases had
pyomyositis, 3 cases had renal and perirenal abscesses, 3
cases had septic osteomyelitis, 3 cases had septic arthritis,
3 cases had urinary tract infections, 2 cases hadFigure 1 Publication yearspneumonia, 2 cases had septic abortions, 1 case had a
prostate abscess and 1 case had a subarachnoid abscess.
Eleven cases had infections at two sites.
Clinical manifestations
In all 168 SPE cases, the symptoms were not specific, most
manifested as bacteremia, dyspnea, chest pain, cough and
other respiratory symptoms as well as symptoms of the
extra pulmonary primary infective focus. There was fever
in 144 cases (85.71%) (the highest temperature, described
in 48 of these 144 cases, was 37.5e40.6 C (mean
38.37  0.92 C)), dyspnea in 81 cases (48.21%), chest pain
in 82 cases (48.81%), cough in 69 cases (41.07%), fatigue in
44 cases (26.19%), anemia in 31 cases (18.45%), hemoptysis
in 24 cases (14.29%), disease progression to respiratory
failure in 26 cases (15.48%), septic shock in 18 cases
(10.71%), empyema in 14 cases (8.33%) and renal insuffi-
ciency in 9 cases (5.36%).
Imaging results
In 168 cases, 135 cases underwent chest X-ray examination,
134 cases chest CT examination, 12 cases enhanced chest
CT examination and 1 case underwent a lung ventilation
perfusion scan. The main imaging findings are shown in
Table 1.
Echocardiography
Altogether, 107 cases were evaluated by echocardiography;
82 by transthoracic echocardiography, 44 by trans-
esophageal echocardiography and 19 by both transthoracic
and transesophageal echocardiography. Echocardiography
revealed vegetations in 52 cases (48.60%), including vege-
tations on the tricuspid valve in 45 cases (86.54%), vege-
tations on the pulmonary valve in 2 cases and vegetations
on the atrium and endocardium in 5 cases (vegetations
attached to the pacemaker in 3 of these 5 cases). In 6
cases, transesophageal echocardiography revealed vegeta-
tions that were not visible with transthoracic
echocardiograghy.
Blood culture results
Altogether, 151 cases underwent blood culture, results
were positive results in 137 cases (90.73%); some cases had
multiple positive blood cultures. Blood cultures grew
methicillin-resistant Staphylococcus aureus (MSSA) in 48of the included articles.
Table 1 Imaging findings of 168 SPE cases.
Imaging findings Chest X-ray n(%) Chest CT n(%)
Bilateral abnormality 110(81.48) 110(82.09)
Nodules opacities 89(65.93) 89(66.42)
Local infiltrates 54(40.00) 48(35.82)
Wedge-shaped lesions 5(3.70) 23(17.16)
Cavitation 44(32.59) 75(55.97)
feeding vessel sign 0 37(27.61)
Pleural effusion 32(23.70) 40(29.85)
4 R. Ye et al.cases, methicillin-sensitive Staphylococcus aureus (MRSA)
in 27 cases, Fusobacteria in 11 cases, Klebsiella pneumo-
niae in 11 cases, Candida in 6 cases and Streptococcus
viridans in 4 cases. The distribution of blood culture results
according to clinical risk factors is shown in Table 2.
Treatment
All cases in this group were treated with antibiotics, usually
for 4e9 weeks; for 122 cases, the course of treatment was
described in detail, as shown in Table 3.
In addition to medical treatment, 18 cases received surgi-
cal treatment, including valve replacement or repair in 7
cases, surgical embolectomy in7casesandcardiac surgery in 4
cases. Twenty-two cases who had empyema and pleural
effusionunderwent closed thoracicdrainage, theabscesses of
16 cases were drained, with the local infected lesions of 5
cases were removed, 14 cases with associated thrombosis
received anticoagulant treatment, and the catheters were
removed from the cases with catheter-related infections.
Outcomes
The outcomes were unknown in 3 cases, 101 cases (60.12%)
were cured, 47 cases (27.98%) were improved and 17 casesTable 2 Blood culture results in SPE patients by clinical risk fa




IV drug abuse 26 11
Catheter-related infection 3 4
Skin and soft tissue infection 10 10
Liver abscess 0 0
Infective endocarditis 0 5
Septic thromobphlebitis 0 3







MSSA: Methicillin-sensitive Staphylococcus aureus; MRSA: Methicillin
Viridians Streptococci.
a Immunocompromised from long-term oral administration of steroi(10.12%) died. The causes of death included septic shock (6
cases), hemoptysis (2 cases), gastrointestinal bleeding (2
cases), pulmonary edema (1 case), recurrent pulmonary
embolism (1 case), multiple organ failure (2 cases), pro-
gressive renal insufficiency (1 case), cerebral hemorrhage
(1 case), tumor (1 case) and unknown cause (1 case). Four
cases underwent autopsy, which revealed emboli in the
pulmonary artery in 2 cases.
Discussion
SPE is a rare but serious disease. Since a study [1] reported
60 cases of SPE in 1978, most of the reports are case reports
with few cases. It can be seen from the distribution of ar-
ticles included in this study by publication years of that the
number of reports of SPE has risen in recent years. In terms
of geographical distribution, SPE has been reported pri-
marily from densely populated countries with more
advanced medical resources, which may be related to the
technologies required to diagnose SPE, as well as the risk
factors for SPE. Therefore, we systematically reviewed the
clinical characteristics of SPE patients reported after 1978,
and thereby identified temporal changes in the epidemio-
logical characteristics of SPE.
The common causes for SPE include intravenous drug
use, infective endocarditis of the tricuspid valve, septic
thrombophlebitis, suppurative angina, periodontal abscess,
purulent infection of skin and soft tissues, pelvic throm-
bophlebitis, intravascular catheters, pacemakers, liver
abscess and hemodialysis [1,58]. In the 1970s, 76%e78% of
the SPE patients were intravenous drug users [1,78]. In this
study, however, only 26.19% were intravenous drug users,
while the 15.5% percent of patients had intravascular
indwelling catheters or pacemakers, which may be related
to the recent increase in use of indwelling catheters for
cancer chemotherapy and parenteral nutrition support.
Moreover, with the development of cardiovascularctors.
m blood cultures
Fusobacterim KP Candida VS
n n n n
2 1 0 0
0 1 5 0
0 1 0 0
0 6 0 0
0 0 1 4
2 0 0 0
5 0 0 0
0 5 1 0
0 0 2 0
0 0 3 0
3 0 0 0
-resistant Staphylococcus aureus; KP: Klebsiella Pneumonia; VS:
ds, splenectomy and other reasons.
Table 3 Patient outcomes of patients by antimicrobial
given for initial treatment and regimen change.
Antimicrobial Outcomes
Improved Cured Dead Regimen change
N n n n
Initial treatment
Penicillins 12 14 4 14
Cephalosporins 9 3 4 13
Quinolones 0 3 0 4
Carbapenems 2 2 1 1
Vancomycin 4 23 0 3
Teicoplanin 2 0 1 0
Amphotericin B 2 0 1 0
Treatment after regimen change
Penicillins 3 4 0
Cephalosporins 4 2 0
Carbapenems 1 7 0
Vancomycin 3 4 0
Daptomycina 2 3 0
a Daptomycin þ rifampicin combination therapy.
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have been used in clinical practice. In this group, SPE was
caused by pacemakers in 5 cases.
The clinical manifestations of SPE patients are not spe-
cific. In these 168 cases, the main clinical manifestations
were fever (85.71%), dyspnea (48.21%), chest pain (48.81%)
and cough (41.07%). Pulmonary thromboembolism patients
also often have dyspnea, chest pain and other symptoms,
and some patients also have fever. However, in such pa-
tients, the highest body temperature rarely exceeds 38.5 C
and extra pulmonary infection lesions are rarely found;
these differences, can help distinguish SPE from pulmonary
thromboembolism.
SPE has unique imaging findings, such as nodules, patchy
infiltrates, cavity and pleural effusion. Most cases have
more than two imaging manifestations simultaneously,
commonly multiple nodules or patchy infiltrates of both
lungs, especially near the pleura, with or without cavity
and pleural effusion. Among the 40 cases with the compli-
cation of pleural effusion, 14 cases had empyema that was
considered related to S. aureus(S. aureus) infection [41], 7
cases were definitively caused by S.aureus. For detection of
pulmonary infiltrates and lesions, X-ray and CT findings
were very similar, but CT could more clearly show more
subtle lesions such as feeding vessels. In 12 cases, the
enhanced chest CT examination clearly indicated the for-
mation of pulmonary arterial emboli, which helped to
better differentiate SPE from simple lung infection, espe-
cially from S. aureus pneumonia.
Echocardiography showed that 86.54% of the vegetations
in the SPE patients were tricuspid vegetations, consistent
with the published reports [79]. SPE is usually considered to
originate from the right ventricular system, consistent with
SPE’s association with intravenous drug use and catheter-
related infection and with the flow of emboli through the
right ventricle leading to pulmonary arterial embolism. The
presence of tricuspid vegetations not only supports the
diagnosis of infective endocarditis, but also helps toindicate the source of septic emboli and contributes to the
diagnosis of SPE. Patients with highly suspected endocardial
vegetations but negative results with transthoracic echo-
cardiography should be evaluated with transesophageal
echocardiography, because the detection rate can be
improved. The incidence of cardiac device endocarditis is
1e7% of those who receive a cardiac device, and 27% car-
diac device endocarditis is associated with SPE [80]. In this
group, right atrial vegetations were found in 6 cases; 4 of
there were attached to the pacemakers. Therefore, for
patients with a cardiac device, if echocardiography sug-
gests infective endocarditis, complicated SPE should be
considered.
S. aureus is the most common pathogen in intravenous
drug abusers and patients with skin and soft tissue and
catheter-related infections. The blood culture results in
this group also revealed that S. aureus was the most
frequent pathogen. Candida is a common pathogen that
causes catheter-related infections. As shown by the blood
culture results in this group, 6 cases were infected with
Candida, which was from intravascular indwelling catheters
in 5 cases who had complicated immune hypofunction or
tumor. A study [81] reported that fungal embolism was
found in 90% of the SPE patients with an underlying disease
of leukemia or lymphoma, prodominantly Candida and
Aspergillus embolism. K. pneumoniae is the pathogen that
most frequently causes liver abscess [82]. The blood culture
in this group grew K. pneumoniae in 11 cases, including 6
cases with liver abscess and 5 cases with diabetes. Fuso-
bacterium is a common oropharyngeal anaerobic genus.
The blood culture in this group grew fusobacteriam in 11
cases, mostly in cases of oropharyngeal infection or
Lemierre’s syndrome.
In this group, 101 cases were cured and 47 cases
improved; all were treated with antibiotics. Initially, the
patients were most frequently treated with broad-
spectrum penicillins and cephalosporins; antibiotics were
adjusted promptly according to the blood culture results.
All patients were treated for 4e9 weeks. For S. aureus
infection, this study indicated that the efficacy of vanco-
mycin in the treatment of MSSA infection was not superior
to that of nafcillin or oxacillin [83]. For blood culture-
positive MRSA infection, the infected lesions should be
removed first; in the event of associated empyma,
adequate drainage should be combined with systemic
intravenous medication. For such infections vancomycin or
daptomycin are recommended for 4e6 weeks; the addition
of gentamicin to vancomycin is not recommended [84]. For
fungal infections, the intravascular indwelling catheters
should be removed first, fluconazole or an echinocandin is
recommended for initial therapy and an echinocandin is
recommended for neutropenic patients. The recommended
duration of therapy for candidemia, without persistent
fungemia or metastatic complications, is 2 weeks after
documented clearance of Candida from the bloodstream,
resolution of symptoms attributable to candidemia and
resolution of neutropenia [85]. SPE treatment usually does
not involve the application of anticoagulants because of the
risk of bleeding of infective emboli. In our study, antico-
agulants were used in 14 cases, usually to treat thrombosis
or thrombophlebitis; 18 cases were treated surgically,
predominately targeted at valvular vegetations. In patients
6 R. Ye et al.with difficult to control infections, the focus of infection be
removed surgically as soon as possible.
Based on the results of our study, SPE should be sus-
pected in high-risk patients with a history of intravenous
drug use or underlying disease, if they have fever, dyspnea,
chest pain and other clinical manifestations and their lung
images suggest multiple nodules or plaques with or without
pleural effusion. Enhanced chest CT examination should be
performed to identify the emboli and blood culture, liver
ultrasonography, echocardiography and other examinations
should be performed to detect the source of the emboli.
Early removal of infected lesions, indwelling catheters or
cardiac devices is highly recommended. Before the results
of blood culture are available, they should be given empiric
antibiotics against S. aureus infection. For patients with
liver abscess, antibiotics active against K. pneumoniae
should be selected. In addition, Candida infection should be
considered in patients with catheter-related infection who
are immunocompromised or have a malignancy.
SPE has a high mortality. Seventeen of the 168 cases in
this review died, including 15 deaths due to SPE; death was
caused most frequently by septic shock accompanied by
multiple organ failure. Therefore, for patients with SPE,
attention should be paid not only the to course of the local
focus of infection but also to end-organ function to detect
and correct shock as early as possible and thereby improve
prognosis.Conflict of interest
YE Rui and other co-authors have no conflict of interest.
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